This site is intended for US residents 18 years of age and older

INDICATIONS AND USAGE

SPRYCEL® (dasatinib) is a prescription medicine used to treat:

  • adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
  • adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including imatinib
  • adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment
  • children 1 year of age and older with Ph+ CML in chronic phase
  • children 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy

It is not known if SPRYCEL is safe and effective in children under 1 year of age.

Hypothetical SPRYCEL® (dasatinib) patient holding a child on their back
Hypothetical SPRYCEL® (dasatinib) patient holding a child on their back

Understanding your diagnosis

Get information that can help you understand your diagnosis and options for support. 

Phases of Ph+ CML

Starting on SPRYCEL

When starting treatment, it’s natural to have a lot of questions. Get helpful information and tips that can help you know what to expect. 

Taking SPRYCEL

Meeting your milestones

See how taking SPRYCEL may help you achieve your treatment milestones and treat your Ph+ CML. 

Ph+ CML Monitoring

With the SPRYCEL® Connect program, we’re here to help you at key moments in your treatment journey, with complimentary support including:

  • Digital Handbook - an interactive treatment guide to help you understand what to expect at every step in your treatment journey
  • Guide to Healthcare Team Roles and Responsibilities
  • Ongoing email support
  • Stories from Real SPRYCEL Patients
Back
to Top